Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors
作者:Jan Kehler、Andreas Ritzen、Morten Langgård、Sebastian Leth Petersen、Mohamed M. Farah、Christoffer Bundgaard、Claus Tornby Christoffersen、Jacob Nielsen、John Paul Kilburn
DOI:10.1016/j.bmcl.2011.04.067
日期:2011.6
Novel triazoloquinazolines have been found as phosphodiesterase 10A (PDE10A) inhibitors. Structure–activity studies improved the initial micromolar potency which was found in the lead compound by a 100-fold identifying 5-(1H-benzoimidazol-2-ylmethylsulfanyl)-2-methyl-[1,2,4]triazolo[1,5-c]quinazoline, 42 (PDE10A IC50 = 12 nM) as the most potent compound from the series. Two X-ray structures revealed
已发现新型三唑并喹唑啉类是磷酸二酯酶10A(PDE10A)抑制剂。结构活性研究提高了铅化合物的初始微摩尔效能,方法是通过100倍鉴定5-(1 H-苯并咪唑-2-基甲基硫烷基)-2-甲基-[1,2,4]三唑[1, 5- c ]喹唑啉,42(PDE10A IC 50 = 12 nM)是该系列中最有效的化合物。两个X射线结构揭示了与PDE10A酶催化位点的新颖结合方式。